Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Urine Proteome of COVID-19 Patients
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Urine Proteome of COVID-19 Patients
Creator
Xu, Ping
Bai, Changqing
Liu, Huiying
Zhu, Li
Wang, Hengliang
Chang, Lei
Chen, Peiru
Ding, Baoqing
Li, Naikang
Li, Yanchang
Li, Zhaodi
Wang, Yihao
Zhao, Yinghua
Source
MedRxiv
abstract
The atypical pneumonia (COVID-19) caused by SARS-CoV-2 is an ongoing pandemic and a serious threat to global public health. The COVID-19 patients with severe symptoms account for a majority of mortality of this disease. However, early detection and effective prediction of patients with mild to severe symptoms remains challenging. In this study, we performed proteomic profiling of urine samples from 32 healthy control individuals and 6 COVID-19 positive patients (3 mild and 3 severe). We found that urine proteome samples from the mild and severe COVID-19 patients with comorbidities can be clearly differentiated from healthy proteome samples based on the clustering analysis. Multiple pathways have been compromised after the COVID-19 infection, including the dysregulation of immune response, complement activation, platelet degranulation, lipoprotein metabolic process and response to hypoxia. We further validated our finding by directly comparing the same patients' urine proteome after recovery. This study demonstrates the COVID-19 pathophysiology related molecular alterations could be detected in the urine and the potential application of urinary proteome in auxiliary diagnosis, severity determination and therapy development of COVID-19.
has issue date
2020-05-06
(
xsd:dateTime
)
bibo:doi
10.1101/2020.05.02.20088666
has license
medrxiv
sha1sum (hex)
829fa4ee7559935bc527f7d3d430ee3689a8c8b3
schema:url
https://doi.org/10.1101/2020.05.02.20088666
resource representing a document's title
Urine Proteome of COVID-19 Patients
resource representing a document's body
covid:829fa4ee7559935bc527f7d3d430ee3689a8c8b3#body_text
is
schema:about
of
named entity 'Urine'
named entity 'COVID-19'
named entity 'Urine'
named entity 'proteomics'
named entity 'Human urine'
named entity 'COVID'
named entity 'cluster analysis'
named entity 'viral infection'
named entity 'COVID'
named entity 'peptides'
named entity 'metabolic'
named entity 'platelet'
named entity 'proteome'
named entity 'medRxiv'
named entity 'SARS-CoV-2'
named entity 'down-regulated'
named entity 'IL-6'
named entity 'proteome'
named entity 'preprint'
named entity 'COVID-19'
named entity 'lung'
named entity 'biomarkers'
named entity 'COVID'
named entity 'degranulation'
named entity 'DTT'
named entity 'preprint'
named entity 'urine'
named entity 'medRxiv'
named entity 'COVID'
named entity 'virus strain'
named entity 'X-ray'
named entity 'platelet'
named entity 'symptom'
named entity 'protein'
named entity 'peptide'
named entity 'proteomics'
named entity 'SARS-CoV-2'
named entity 'medRxiv'
named entity 'peer review'
named entity 'medRxiv'
named entity 'lipid'
named entity 'SARS-CoV'
named entity 'proteome'
named entity 'protein'
named entity 'protein'
named entity 'comorbidities'
named entity 'medRxiv'
named entity 'Cubilin'
named entity 'medRxiv'
named entity 'proteome'
named entity 'preprint'
named entity 'SARS-CoV-2'
named entity 'proteome'
named entity 'pathogenesis'
named entity 'essential hypertension'
named entity 'urine'
named entity 'Interleukin-6'
named entity 'medRxiv'
named entity 'infectious disease'
named entity 'COVID-19 pandemic'
named entity 'antiviral therapies'
named entity 'COVID-19'
named entity 'urine'
named entity 'preprint'
named entity 'preprint'
named entity 'COVID'
named entity 'endoplasmic reticulum'
named entity 'pneumonia'
named entity 'metabolic process'
named entity 'angiotensin-converting enzyme 2'
named entity 'Human Protein Atlas'
named entity 'Computed Tomography'
named entity 'global healthcare'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 5
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software